Complete inhibition of ABCB1 and ABCG2 at the blood–brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1/ABCG2 substrate [(11)C]erlotinib

P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) restrict at the blood–brain barrier (BBB) the brain distribution of the majority of currently known molecularly targeted anticancer drugs. To improve brain delivery of dual ABCB1/ABCG2 substrates, both ABCB1 and ABCG2 need to be inh...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Cereb Blood Flow Metab
Asıl Yazarlar: Tournier, Nicolas, Goutal, Sebastien, Mairinger, Severin, Hernández-Lozano, Irene, Filip, Thomas, Sauberer, Michael, Caillé, Fabien, Breuil, Louise, Stanek, Johann, Freeman, Anna F, Novarino, Gaia, Truillet, Charles, Wanek, Thomas, Langer, Oliver
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2020
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8221757/
https://ncbi.nlm.nih.gov/pubmed/33081568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0271678X20965500
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller